ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-37E5718
Home | Market Reports | Health| Health Conditions| Cancer
Global B Cell Non Hodgkin s Lymphoma NHL Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Research Report 2025

Code: QYRE-Auto-37E5718
Report
June 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Bayer
Bristol–Myers Squibb
Merck Serono
Roche
Astrazeneca plc
AbbVie
Novartis

B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market

B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market

The global market for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment.
The B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Report

Report Metric Details
Report Name B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Bayer, Bristol-Myers Squibb, Merck Serono, Roche, AstraZeneca, AbbVie, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market report?

Ans: The main players in the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market are Amgen, Bayer, Bristol-Myers Squibb, Merck Serono, Roche, AstraZeneca, AbbVie, Novartis

What are the Application segmentation covered in the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market report?

Ans: The Applications covered in the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market report are Hospitals, Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market report?

Ans: The Types covered in the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market report are Chemotherapy, Radiation Therapy, Others

Recommended Reports

Lymphoma Treatments

Leukemia & Blood Cancer

Cancer Therapy Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Perspective (2020-2031)
2.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Growth Trends by Region
2.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Region (2020-2025)
2.2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2026-2031)
2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Dynamics
2.3.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Trends
2.3.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers
2.3.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges
2.3.4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue
3.1.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue (2020-2025)
3.1.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue
3.4 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio
3.4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2024
3.5 Global Key Players of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Head office and Area Served
3.6 Global Key Players of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, Product and Application
3.7 Global Key Players of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Type
4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Type (2020-2025)
4.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2026-2031)
5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Application
5.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Application (2020-2025)
5.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2020-2031)
6.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025)
6.4 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2020-2031)
7.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025)
7.4 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2020-2031)
8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2020-2031)
9.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025)
9.4 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2020-2031)
10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.1.4 Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.2.4 Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Merck Serono
11.4.1 Merck Serono Company Details
11.4.2 Merck Serono Business Overview
11.4.3 Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.4.4 Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.4.5 Merck Serono Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.5.4 Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.5.5 Roche Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.6.4 AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.7.4 AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.7.5 AbbVie Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.8.4 Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
11.8.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Amgen Inc
Bayer
Bristol–Myers Squibb
Merck Serono
Roche
Astrazeneca plc
AbbVie
Novartis
List of Tables
 Table 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemotherapy
 Table 3. Key Players of Radiation Therapy
 Table 4. Key Players of Others
 Table 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2020-2025)
 Table 9. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2026-2031)
 Table 11. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Trends
 Table 12. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers
 Table 13. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges
 Table 14. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints
 Table 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players (2020-2025)
 Table 17. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2024)
 Table 18. Ranking of Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, Headquarters and Area Served
 Table 21. Global Key Players of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, Product and Application
 Table 22. Global Key Players of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Amgen Company Details
 Table 48. Amgen Business Overview
 Table 49. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 50. Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 51. Amgen Recent Development
 Table 52. Bayer Company Details
 Table 53. Bayer Business Overview
 Table 54. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 55. Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 56. Bayer Recent Development
 Table 57. Bristol-Myers Squibb Company Details
 Table 58. Bristol-Myers Squibb Business Overview
 Table 59. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 60. Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 61. Bristol-Myers Squibb Recent Development
 Table 62. Merck Serono Company Details
 Table 63. Merck Serono Business Overview
 Table 64. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 65. Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 66. Merck Serono Recent Development
 Table 67. Roche Company Details
 Table 68. Roche Business Overview
 Table 69. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 70. Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 71. Roche Recent Development
 Table 72. AstraZeneca Company Details
 Table 73. AstraZeneca Business Overview
 Table 74. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 75. AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 76. AstraZeneca Recent Development
 Table 77. AbbVie Company Details
 Table 78. AbbVie Business Overview
 Table 79. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 80. AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 81. AbbVie Recent Development
 Table 82. Novartis Company Details
 Table 83. Novartis Business Overview
 Table 84. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
 Table 85. Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025) & (US$ Million)
 Table 86. Novartis Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Picture
 Figure 2. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Chemotherapy Features
 Figure 5. Radiation Therapy Features
 Figure 6. Others Features
 Figure 7. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Ambulatory Surgical Centers Case Studies
 Figure 12. Others Case Studies
 Figure 13. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Report Years Considered
 Figure 14. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region: 2024 VS 2031
 Figure 17. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players in 2024
 Figure 18. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2024
 Figure 20. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2020-2031)
 Figure 22. United States B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2020-2031)
 Figure 26. Germany B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2020-2031)
 Figure 34. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2020-2031)
 Figure 42. Mexico B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Country (2020-2031)
 Figure 46. Turkey B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Amgen Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 50. Bayer Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 51. Bristol-Myers Squibb Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 52. Merck Serono Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 54. AstraZeneca Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Non Hodgkin Lymphoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lymphoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global B Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2024
Intraocular Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cutaneous B Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Marginal Zone Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Hodgkin s Lymphoma and Chronic Lymphoma Treatment Market Research Report 2024
Global Hodgkin Lymphoma Treatment Market Research Report 2025
Global Diffuse Large B Cell Lymphoma Drug Market Research Report 2024
Hematological Malignancies Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
T Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cutaneous Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Lymphocytic Lymphoma Therapy Market Research Report 2025
Global Indolent Lymphoma Treatment Market Research Report 2025
Central Nervous System CNS Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematological Malignancy Treatment Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions